JPRN-jRCT1090220035已完成3 期
Multicenter study evaluating safety and the performance of the intracranial stent system (WS-01) for the treatment of intracranial atherosclerotic disease - WS-01
Kobe City Hospital Organization General HospitalNobuyuki Sakai0 个研究点目标入组 20 人开始时间: 2010年3月9日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •patients treated with WS-01 stent for recurrent stroke attributable to intracranial atherosclerotic disease, refractory to medical treatment, in intracranial vessels
排除标准
- 未提供
研究者
相似试验
已完成
3 期
WS-01 Investigator-initiated clinical trialJPRN-jRCT1092220031obuyuki Sakai, Kobe City Hospital Organization Kobe City Medical Center General Hospital20
已完成
不适用
Multicenter study to evaluate safety and performance of Geistlich Bio-Graft® for horizontal ridge augmentationridge width insufficient for placement of dental implantsDRKS00006107Geistlich Pharma AG38
招募中
不适用
Multicenter clinical study evaluating safety and efficacy of iron chelation therapy in patients with transfusion-induced iron overloadTransfusion-induced iron overloadJPRN-UMIN000002515The National Research Group on Idiopathic Bone Marrow Failure Syndromes in Japan100
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioEUCTR2014-001971-30-FIovartis Pharma services AG5,000
进行中（未招募）
1 期
Safety and tolerability during open-label treatment with LCZ696 in patients with chronic heart failure and reduced ejection fractioHeart failure with reduced ejection fractionMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849EUCTR2014-001971-30-LTovartis Pharma Services AG5,000